Partnerships: MedClean Inks Canada Distribution Deal
July 14, 2010 (FinancialWire) (Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news.) — MedClean Technologies (OTCBB: MCLN), a provider of onsite technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, said it has signed a distributor agreement with Ace Technologies, Inc., a provider of network solutions, security, and monitoring services in Canada.
To facilitate distribution, Ace has formed a new company, MedClean Canada, to deliver integrated onsite medical waste disposal and onsite document destruction technology and services to target over 2,000 Canadian Hospitals.
Each party said it expects to recognize $1 million to $2 million in revenue in the first year of the agreement.
According to MedClean, MedClean Canada will be responsible for the entire country as it expands its sales force and opens remote offices in the Prairie Region and Vancouver.
It said that Ace Technologies has established relationships with 41 hospitals throughout Canada for network solutions, security, and monitoring services, and MedClean Canada anticipates leveraging this installed base and the existing relationships, targeting a large number of hospitals throughout Canada as potential customers.
Connecticut-based MedClean Technologies’ flagship MedClean Series systems are designed to enable hospitals and other healthcare providers to convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste.
MedClean was founded in 1997.
Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html). Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).
FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Copyright © MMX, FinancialWire(tm); All rights reserved.
[hlmsmlh] [prtnrshpsphs] [nwdlsldw] [ntrntnlcmpnsbsnss] [cndnexh] [hlthcrdp] [prfssnlsrvctsrc] [ntrntnlcmpnsbsnss] [ftrdnwswnd] [tchnlgy]
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.